Multifunctional nanocomposites DDMplusAF inhibit the proliferation and enhance the radiotherapy of breast cancer cells via modulating tumor-promoting factors and metabolic reprogramming.

MLA

Thabet, Noura M., et al. “Multifunctional Nanocomposites DDMplusAF Inhibit the Proliferation and Enhance the Radiotherapy of Breast Cancer Cells via Modulating Tumor-Promoting Factors and Metabolic Reprogramming.” Cancer Nanotechnology (1868-6958), vol. 13, no. 1, May 2022, pp. 1–31. EBSCOhost, https://doi.org/10.1186/s12645-022-00122-1.

APA

Thabet, N. M., Abdel-Rafei, M. K., El-Sayyad, G. S., Elkodous, M. A., Shaaban, A., Du, Y.-C., Rashed, L. A., & Askar, M. A. (2022). Multifunctional nanocomposites DDMplusAF inhibit the proliferation and enhance the radiotherapy of breast cancer cells via modulating tumor-promoting factors and metabolic reprogramming. Cancer Nanotechnology (1868-6958), 13(1), 1–31. https://doi.org/10.1186/s12645-022-00122-1

Chicago

Thabet, Noura M., Mohamed K. Abdel-Rafei, Gharieb S. El-Sayyad, Mohamed Abd Elkodous, Adel Shaaban, Yi-Chun Du, Laila Ahmed Rashed, and Mostafa A. Askar. 2022. “Multifunctional Nanocomposites DDMplusAF Inhibit the Proliferation and Enhance the Radiotherapy of Breast Cancer Cells via Modulating Tumor-Promoting Factors and Metabolic Reprogramming.” Cancer Nanotechnology (1868-6958) 13 (1): 1–31. doi:10.1186/s12645-022-00122-1.